Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis

dc.date.accessioned	2023-03-06T07:32:37Z
dc.date.available	2023-03-06T07:32:37Z
dc.date.issued	2022
dc.identifier.citation	North Clin Istanb. 2022 Oct 27;9(5):505-513. doi: 10.14744/nci.2022.04935. eCollection 2022.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100387
dc.relation.isversionof	10.14744/nci.2022.04935
dc.relation.isversionof	10.14744/nci.2022.04935
dc.title	Rifaximine spacer application is not superior to local teicoplanin treatment in a rat model of osteomyelitis
dc.relation.journal	North Clin Istanb
dc.identifier.doi	10.14744/nci.2022.04935
dc.contributor.author	Yucel MO
dc.contributor.author	Yucel MO
dc.contributor.author	Turhan Y
dc.contributor.author	Arican M
dc.contributor.author	Karaduman ZO
dc.contributor.author	Saglam S
dc.contributor.author	Tekce Y
dc.contributor.author	Gamsizkan M.